Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
Liu Y, Xu J, Choi HH, Han C, Fang Y, Li Y, Van der Jeught K, Xu H, Zhang L, Frieden M, Wang L, Eyvani H, Sun Y, Zhao G, Zhang Y, Liu S, Wan J, Huang C, Ji G, Lu X, He X, Zhang X.
Liu Y, et al.
Nat Commun. 2018 Nov 9;9(1):4718. doi: 10.1038/s41467-018-07264-0.
Nat Commun. 2018.
PMID: 30413718
Free PMC article.